Koutris; Efthimios

Patent Applications and Registrations

Patent applications and USPTO patent grants for Koutris; Efthimios.The latest application filed is for "stable injectable pharmaceutical composition of neurokinin 1 receptor antagonist and process for preparation thereof".

Company Profile

10.14.22

Koutris; Efthimios - Pallini Attikis N/A GR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Preservative free pharmaceutical compositions for ophthalmic administration Grant 10,772,830 - Karavas , et al. September 15, 2	2020-09-15
Stable Injectable Pharmaceutical Composition Of Neurokinin 1 Receptor Antagonist And Process For Preparation Thereof App 20200237920 - KARAVAS; EVANGELOS ; et al.	2020-07-30
Preservative free pharmaceutical compositions for ophthalmic administration Grant 10,702,471 - Karavas , et al.	2020-07-07
Preservative Free Pharmaceutical Compositions For Ophthalmic Administration App 20190269612 - KARAVAS; EVANGELOS ; et al.	2019-09-05
Preservative free pharmaceutical compositions for ophthalmic administration Grant 10,350,161 - Karavas , et al. July 16, 2	2019-07-16
Pharmaceutical Composition Comprising An Atypical Antipsychotic Agent And Method For The Preparation Thereof App 20190105277 - KARAVAS; Evangelos ; et al.	2019-04-11
Pharmaceutical composition containing phosphate binding polymer Grant 9,849,147 - Karavas , et al. December 26, 2	2017-12-26
Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof Grant 9,675,551 - Karavas , et al. June 13, 2	2017-06-13
Method for improving the bioavailability of low aqueous solubility drugs Grant 9,561,186 - Karavas , et al. February 7, 2	2017-02-07
Preservative Free Pharmaceutical Compositions For Ophthalmic Administration App 20160263023 - KARAVAS; EVANGELOS ; et al.	2016-09-15
Novel Method For Improving The Bioavailability Of Low Aqueous Solubility Drugs App 20150290137 - Karavas; Evangelos ; et al.	2015-10-15
Pharmaceutical Composition Comprising An Atypical Antipsychotic Agent And Method For The Preparation Thereof App 20150231080 - Karavas; Evangelos ; et al.	2015-08-20
Pharmaceutical Composition Containing Phosphate Binding Polymer App 20150182555 - Karavas; Evangelos ; et al.	2015-07-02
Stable Injectable Pharmaceutical Composition Of Neurokinin 1 Receptor Antagonist And Process For Preparation Thereof App 20150165045 - Karavas; Evangelos ; et al.	2015-06-18
Ophthalmic Pharmaceutical Composition Containing A Carbonic Anhydrase Inhibitor And Method For The Preparation Thereof App 20150080385 - Karavas; Evangelos ; et al.	2015-03-19
Pharmaceutical formulation containing an HMG-COA reductase inhibitor and method for the preparation thereof Grant 8,835,486 - Karavas , et al. September 16, 2	2014-09-16
Stable Injectable Pharmaceutical Composition Of Vitamin D Receptor Agonist And Process For Preparation Thereof App 20140187520 - KOUTRIS; EFTHIMIOS ; et al.	2014-07-03
Pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof Grant 8,187,635 - Karavas , et al. May 29, 2	2012-05-29
Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof App 20110065751 - Karavas; Evangelos ; et al.	2011-03-17
Pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof App 20110033538 - Karavas; Evangelos ; et al.	2011-02-10
Sustained-release Pharmaceutical Formulation Containing An Antimuscarinic Agent And A Wetting Agent As Well As A Process For The Preparation Thereof App 20100297225 - Karavas; Evangelos ; et al.	2010-11-25
Pharmaceutical Formulation containing an HMG-COA Reductase Inhibitor and method for the preparation thereof App 20100196469 - Karavas; Evangelos ; et al.	2010-08-05
Pharmaceutical Formulation Containing An Hmg-coa Reductase Inhibitor And Method For The Preparation Thereof App 20100137400 - Karavas; Evangelos ; et al.	2010-06-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.